Cargando…

Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development

PURPOSE: Propranolol has been successful in treating problematic infantile hemangiomas (IH) but concerns regarding its effect on normal growth and development have been raised. This study examines physical growth, developmental milestones, and human growth hormone (hGH) levels in infants receiving p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giese, Rachel A., Turner, Merit, Cleves, Mario, Gardner, J. Reed, Richter, Gresham T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049833/ https://www.ncbi.nlm.nih.gov/pubmed/33927773 http://dx.doi.org/10.1155/2021/6669383

Ejemplares similares

Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas
por: Phillips, James D., et al.
Publicado: (2021)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration
por: Gomez-Acevedo, Horacio, et al.
Publicado: (2020)

Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)

Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021)

Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study
por: Abu-Rmaileh, Muhammad, et al.
Publicado: (2022)

Mechanisms of propranolol action in infantile hemangioma
por: Kum, Jina JY, et al.
Publicado: (2015)

When to stop propranolol for infantile hemangioma
por: Chang, Lei, et al.
Publicado: (2017)

Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023)

Severe hypoglycemia in propranolol treatment for infantile hemangiomas
por: Morimoto, Akira, et al.
Publicado: (2022)

The impact of propranolol on the growth and development of children with proliferative infantile hemangioma during treatment
por: Lin, Xiangshang, et al.
Publicado: (2023)

Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence
por: Xiao, Qiang, et al.
Publicado: (2013)

Efficacy of infantile hepatic hemangioma with propranolol treatment: A case report
por: Tsai, Mu-Chieh, et al.
Publicado: (2019)

Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile Hemangioma
por: Takechi, Tomoki, et al.
Publicado: (2018)

Variable Response to Propranolol Therapy for Infantile Hemangiomas
por: Jain, Vishesh, et al.
Publicado: (2012)

Excellent response of infantile orbital hemangioma to propranolol
por: Sendrasoa, Fandresena A, et al.
Publicado: (2016)

Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas
por: Praticò, Andrea Domenico, et al.
Publicado: (2015)

Propranolol therapy for infantile hemangioma: our experience
por: Zhang, Ling, et al.
Publicado: (2017)

Commentary: Propranolol for infantile hemangiomas — The intralesional route
por: Tripathy, Devjyoti
Publicado: (2019)

Propranolol-induced hyperkalemia in the management of infantile hemangioma
por: Al-Rwebah, Huda, et al.
Publicado: (2020)

Early propranolol treatment of infantile hemangiomas improves outcome()
por: Giachetti, Ana, et al.
Publicado: (2023)

Multiple Infantile Hemangiomas Treated Successfully with Oral Propranolol
por: Purkait, Radheshyam, et al.
Publicado: (2016)

Therapeutic Effect of Propranolol in Mexican Patients with Infantile Hemangioma
por: Castaneda, Saul, et al.
Publicado: (2015)

Neonatal Abdominal Hemangiomatosis: Propranolol beyond Infantile Hemangioma
por: Nip, Siu Ying Angel, et al.
Publicado: (2016)

Induction of apoptosis in infantile hemangioma endothelial cells by propranolol
por: TU, JUN-BO, et al.
Publicado: (2013)

Oral propranolol therapy in 23 infants with infantile hemangioma
por: Kim, Jaeyoon, et al.
Publicado: (2018)

Infantile Hemangioma Treated with Oral Propranolol: Case Presentation
por: Raufi, Nahid, et al.
Publicado: (2021)

Management of infantile subglottic hemangioma with T-tube placement and propranolol
por: D’Ambrosio, Paula Duarte, et al.
Publicado: (2022)

Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas
por: Pensabene, Marco, et al.
Publicado: (2022)

Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children
por: Hassan, Basheir A., et al.
Publicado: (2014)

The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol
por: Castaneda, Saul, et al.
Publicado: (2016)

Dermoscopic features of infantile hemangioma during treatment with topical propranolol
por: Valdebran, Manuel, et al.
Publicado: (2020)

A transcription factor is the target of propranolol treatment in infantile hemangioma
por: Schrenk, Sandra, et al.
Publicado: (2022)

Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients with Infantile Hemangiomas
por: Green, Jackson, et al.
Publicado: (2023)

A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021)

Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro
por: ZHU, YALIN, et al.
Publicado: (2014)

Oral Propranolol in Infantile Hemangiomas: Analysis of Factors that Affect the Outcome
por: Ainipully, Arun Mohanan, et al.
Publicado: (2019)

Deep coma in a child treated with propranolol for infantile hemangioma
por: Bakalli, Ilirjana, et al.
Publicado: (2019)

Propranolol-induced hyperkalemia in infantile hemangioma patients: How serious is it?
por: Alakeel, Abduallah, et al.
Publicado: (2022)

Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis
por: STILES, JESSICA, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2ch2e3et417tb2nk0uv7i5m85j